Evidence map›Paper›PMID 24549503›Full record

ArticleNeurotoxicity research2014

Methamphetamine induces low levels of neurogenesis in striatal neuron subpopulations and differential motor performance.

I K Tulloch, L Afanador, L Baker, D Ordonez, H Payne, I Mexhitaj, E Olivares, A Chowdhury, J A Angulo

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicity research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Decreased Expression of Plasma MicroRNA in Patients with Methamphetamine (MA) Use Disorder.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

I K TullochDepartment of Biological Sciences, Hunter College, 695 Park Avenue, New York, NY, 10065, USA.
L Afanador
L Baker
D Ordonez
H Payne
I Mexhitaj
E Olivares
A Chowdhury
J A Angulo
Hunter College · USThe Graduate Center, CUNY · US

Funding

WILD TYPE &MUTANT P53 INTERACTIONS WITH HIV LTR DNAG12RR003037 · NCRR · HUNTER COLLEGE · PI STEIPER, MICHAEL E · 1985 to 2011
$27.6M
Basic and Translational Research Center for Reducing Health DisparitiesG12MD007599 · NIMHD · HUNTER COLLEGE · PI ANGULO, JESUS A · 2012 to 2017
$14.6M
Undergraduate Biomedical Research Training at HunterT34GM007823 · NIGMS · HUNTER COLLEGE · PI FORD, JENNIFER S · 1985 to 2020
$8.2M
Methamphetamine and the Striatal NK-1 ReceptorsR01DA020142 · NIDA · HUNTER COLLEGE · PI ANGULO, JESUS A · 2006 to 2010
$1.1M
NCRR NIH HHS G12 RR003037NIDA NIH HHS R01 DA020142NIGMS NIH HHS T34 GM007823NIMHD NIH HHS 8 G12 MD007599NIMHD NIH HHS G12 MD007599
6 · The paper itself

Abstract

Methamphetamine (METH) causes significant loss of some striatal projection and interneurons. Recently, our group reported on the proliferation of new cells 36 h after METH and some of the new cells survive up to 12 weeks (Tulloch et al., Neuroscience 193:162-169, 2011b). We hypothesized that some of these cells will differentiate and express striatal neuronal phenotypes. To test this hypothesis, mice were injected with METH (30 mg/kg) followed by a single BrdU injection (100 mg/kg) 36 h after METH. One week after METH, a population of BrdU-positive cells expressed the neuronal progenitor markers nestin (18 %) and β-III-tubulin (30 %). At 8 weeks, 14 % of the BrdU-positive cells were also positive for the mature neuron marker, NeuN. At 12 weeks, approximately 7 % of the BrdU-positive cells co-labeled with ChAT, PV or DARPP-32. We measured motor coordination on the rotarod and psychomotor activity in the open-field. At 12 weeks, METH-injected mice exhibited delayed motor coordination deficits. In contrast, open-field tests revealed that METH-injected mice compared to saline mice displayed psychomotor deficits at 2.5 days but not at 2 or more weeks after METH. Taken together, these data demonstrate that some of the new cells generated in the striatum differentiate and express the phenotypes of striatal neurons. However, the proportion of these new neurons is low compared to the proportion that died by apoptosis 24 h after the METH injection. More studies are needed to determine if the new neurons are functional.

Indexed as

AnimalsApoptosisCentral Nervous System StimulantsCholine O-AcetyltransferaseCorpus StriatumDNA-Binding ProteinsDopamine and cAMP-Regulated Phosphoprotein 32Exploratory BehaviorMaleMethamphetamineMice, Inbred ICRMotor ActivityNerve Tissue ProteinsNestinNeural Stem CellsNeurogenesisbeta3 tubulin, mouseCentral Nervous System StimulantsCholine O-AcetyltransferaseDNA-Binding ProteinsDopamine and cAMP-Regulated Phosphoprotein 32MethamphetamineNerve Tissue ProteinsNes protein, mouseNestinNeuN protein, mouseNuclear ProteinsParvalbuminsPpp1r1b protein, mouseTubulin

Identifiers

PMID24549503
PMCPMC4071120
OpenAlexW2078990453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.